Clinical Trial Update: Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients

View source ↗

Summary

A completed trial evaluating Fragmin (dalteparin) for treatment of acute deep vein thrombosis in cancer patients, with or without pulmonary embolism, has posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Deep Vein Thrombosis
• Pulmonary Embolism

Drugs mentioned

• FRAGMIN (DALTEPARIN SODIUM)

Snippet

Sponsor: Pfizer | Conditions: Acute Deep Vein Thrombosis | Status: COMPLETED | Results posted: 2010-08-10